Ki-67和CK-19是甲状腺乳头状癌局部区域复发的预测指标。 - Suppr

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

作者信息

Viana Aline de Oliveira Ribeiro, Gonçalves Filho João, Francisco Ana Lúcia Noronha, Pinto Clóvis Antônio Lopes, Kowalski Luiz Paulo

机构信息

Department of Head and Neck Surgery and Otorhinolaryngology, Heliopolis Hospital, São Paulo, Brazil.

Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, Brazil.

出版信息

Acta Otorhinolaryngol Ital. 2020 Jun;40(3):190-197. doi: 10.14639/0392-100X-N0311.

DOI:10.14639/0392-100X-N0311

PMID:32773780

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7416367/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/83c0/7416367/3a5cd2625d2a/aoi-2020-03-190-g001.jpg

相似文献

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

Acta Otorhinolaryngol Ital. 2020 Jun;40(3):190-197. doi: 10.14639/0392-100X-N0311.

A comparison of the 7th and 8th editions of the AJCC staging system in terms of predicting recurrence and survival in patients with papillary thyroid carcinoma.

Oral Oncol. 2018 Dec;87:158-164. doi: 10.1016/j.oraloncology.2018.11.003. Epub 2018 Nov 9.

Comparison of proliferating cell nuclear antigen, thyroid transcription factor-1, Ki-67, p63, p53 and high-molecular weight cytokeratin expressions in papillary thyroid carcinoma, follicular carcinoma, and follicular adenoma.

Ann Diagn Pathol. 2011 Apr;15(2):108-16. doi: 10.1016/j.anndiagpath.2010.11.005.

Programmed Death-Ligand 1 (PD-L1) Is a Potential Biomarker of Disease-Free Survival in Papillary Thyroid Carcinoma: a Systematic Review and Meta-Analysis of PD-L1 Immunoexpression in Follicular Epithelial Derived Thyroid Carcinoma.

Endocr Pathol. 2020 Sep;31(3):291-300. doi: 10.1007/s12022-020-09630-5.

Clinical significance of BRAF mutation in thyroid papillary cancer.

Otolaryngol Head Neck Surg. 2013 Jun;148(6):919-25. doi: 10.1177/0194599813481942. Epub 2013 Mar 12.

Survival Analysis of Papillary Thyroid Carcinoma in Relation to Stage and Recurrence Risk: A 20-Year Experience in Pakistan.

Clin Nucl Med. 2016 Aug;41(8):606-13. doi: 10.1097/RLU.0000000000001237.

Evaluating the 2015 American Thyroid Association Risk Stratification System in High-Risk Papillary and Follicular Thyroid Cancer Patients.

Thyroid. 2019 Aug;29(8):1073-1079. doi: 10.1089/thy.2019.0053. Epub 2019 Jul 17.

TERT promoter mutations and Ki-67 labeling index as a prognostic marker of papillary thyroid carcinomas: combination of two independent factors.

Sci Rep. 2017 Feb 2;7:41752. doi: 10.1038/srep41752.

Recurrence following hemithyroidectomy in patients with low- and intermediate-risk papillary thyroid carcinoma.

Br J Surg. 2020 May;107(6):687-694. doi: 10.1002/bjs.11430. Epub 2020 Feb 5.

A novel gene panel for prediction of lymph-node metastasis and recurrence in patients with thyroid cancer.

Surgery. 2020 Jan;167(1):73-79. doi: 10.1016/j.surg.2019.06.058. Epub 2019 Nov 9.

引用本文的文献

New Horizons of Biomarkers in Metastatic Thyroid Cancer.

J Cancer. 2025 Jan 1;16(1):241-264. doi: 10.7150/jca.101395. eCollection 2025.

The diagnosis and management of small and indeterminate lymph nodes in papillary thyroid cancer: preoperatively and intraoperatively.

Front Endocrinol (Lausanne). 2024 Nov 14;15:1484838. doi: 10.3389/fendo.2024.1484838. eCollection 2024.

Prognostic factors of papillary and follicular carcinomas based on pre-, intra-, and post-operative findings.

Eur Thyroid J. 2024 Oct 4;13(5). doi: 10.1530/ETJ-24-0196. Print 2024 Oct 1.

The Role of SPECT/CT and PET/CT Hybrid Imaging in the Management of Ectopic Thyroid Carcinoma-A Systematic Review.

Diagnostics (Basel). 2024 Jun 27;14(13):1369. doi: 10.3390/diagnostics14131369.

Clinical and Paraclinical Considerations Regarding ki67's Role in the Management of Differentiated Thyroid Carcinoma-A Literature Review.

Medicina (Kaunas). 2024 May 7;60(5):769. doi: 10.3390/medicina60050769.

Prognostic value of the immunohistochemical score based on four markers in head and neck squamous cell carcinoma.

Front Immunol. 2023 Feb 22;14:1076890. doi: 10.3389/fimmu.2023.1076890. eCollection 2023.

Diagnostic, Prognostic, and Predictive Role of Ki67 Proliferative Index in Neuroendocrine and Endocrine Neoplasms: Past, Present, and Future.

Endocr Pathol. 2023 Mar;34(1):79-97. doi: 10.1007/s12022-023-09755-3. Epub 2023 Feb 17.

Comparison of the Differential Diagnostic Performance of Intravoxel Incoherent Motion Imaging and Diffusion Kurtosis Imaging in Malignant and Benign Thyroid Nodules.

Front Oncol. 2022 Jul 22;12:895972. doi: 10.3389/fonc.2022.895972. eCollection 2022.

Immunohistochemical Profile of Parathyroid Tumours: A Comprehensive Review.

Int J Mol Sci. 2022 Jun 23;23(13):6981. doi: 10.3390/ijms23136981.

Development of a Colloidal Gold Immunochromatographic Strip for Rapid Detection of Cyfra 21-1 in Lymph Node Metastasis of Thyroid Cancer.

Front Bioeng Biotechnol. 2022 Apr 12;10:871285. doi: 10.3389/fbioe.2022.871285. eCollection 2022.

本文引用的文献

Can preoperative serum thyroglobulin levels predict the risk of malignancy? Results from prospective analysis of biochemical predictors of malignancy in thyroid nodules.

Acta Otorhinolaryngol Ital. 2020 Feb;40(1):33-37. doi: 10.14639/0392-100X-N0276.

Clinical utility of an ultrasensitive thyroglobulin assay in the follow-up of patients with differentiated thyroid cancer: can the stimulation test be avoided in patients with an intermediate recurrence risk?

Acta Otorhinolaryngol Ital. 2018 Jun;38(3):188-193. doi: 10.14639/0392-100X-1494.

The clinicopathological significance of Ki67 in papillary thyroid carcinoma: a suitable indicator?

World J Surg Oncol. 2018 May 31;16(1):100. doi: 10.1186/s12957-018-1384-8.

CK7/CK19 index: A potential prognostic factor for postoperative intrahepatic cholangiocarcinoma patients.

J Surg Oncol. 2018 Jun;117(7):1531-1539. doi: 10.1002/jso.25027. Epub 2018 Mar 7.

Ki-67 expression predicts biochemical recurrence after radical prostatectomy in the setting of positive surgical margins.

BMC Urol. 2018 Mar 5;18(1):13. doi: 10.1186/s12894-018-0330-y.

The diagnostic and prognostic values of Ki-67/MIB-1 expression in thyroid cancer: a meta-analysis with 6,051 cases.

Onco Targets Ther. 2017 Jul 3;10:3261-3276. doi: 10.2147/OTT.S135593. eCollection 2017.

Study of Immunohistochemical Markers (CK-19, CD-56, Ki-67, p53) in Differentiating Benign and Malignant Solitary Thyroid Nodules with special Reference to Papillary Thyroid Carcinomas.

J Clin Diagn Res. 2016 Dec;10(12):EC14-EC19. doi: 10.7860/JCDR/2016/22428.9114. Epub 2016 Dec 1.

CK19 and Glypican 3 Expression Profiling in the Prognostic Indication for Patients with HCC after Surgical Resection.

PLoS One. 2016 Mar 15;11(3):e0151501. doi: 10.1371/journal.pone.0151501. eCollection 2016.

2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer.

Thyroid. 2016 Jan;26(1):1-133. doi: 10.1089/thy.2015.0020.

Postoperative recurrence of papillary thyroid carcinoma with lymph node metastasis.

J Surg Oncol. 2015 Aug;112(2):149-54. doi: 10.1002/jso.23967. Epub 2015 Jul 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

作者信息

Viana Aline de Oliveira Ribeiro, Gonçalves Filho João, Francisco Ana Lúcia Noronha, Pinto Clóvis Antônio Lopes, Kowalski Luiz Paulo

机构信息

Department of Head and Neck Surgery and Otorhinolaryngology, Heliopolis Hospital, São Paulo, Brazil.

Department of Head and Neck Surgery and Otorhinolaryngology, A.C. Camargo Cancer Center, São Paulo, Brazil.

出版信息

Acta Otorhinolaryngol Ital. 2020 Jun;40(3):190-197. doi: 10.14639/0392-100X-N0311.

DOI:10.14639/0392-100X-N0311

PMID:32773780

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7416367/

Abstract

摘要

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

Ki-67 and CK-19 are predictors of locoregional recurrence in papillary thyroid carcinoma.

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献